Global Acromegaly Treatment Market to Reach US$ 3.34 Billion by 2034: Growth Trends and Opportunities
Acromegaly is a rare and chronic endocrine disorder characterized by excessive production of growth hormone, usually resulting from a benign pituitary tumor. The condition can lead to progressive physical changes and serious complications involving the cardiovascular, metabolic, respiratory, and musculoskeletal systems if not effectively managed. Increasing disease awareness, advances in...
0 Comments 0 Shares 51 Views 0 Reviews